The biopharmaceutical market in the Asian region shows enormus growth potential. The internationally active ZETA Group has established itself as an end-to-end solution. ZETA Biosystem aims to improve its integration into the international ZETA Group
An Exciting Transition for India’s Biopharmaceutical Industry
BIOTREE, a leading biopharmaceutical engineering and process equipment company in India, has rebranded as ZETA Biosystem. This change strengthens the company’s integration into the international ZETA Group and the expansion of its services to become a global end-to-end solution provider. Customers can now benefit from their new state-of-the-art Experience Centre in Bengaluru, India.
BIOTREE had established itself as an end-to-end solution provider for Asia’s biopharmaceutical industry, offering design, construction, automation, digitalization, and qualification services for customer-specific biopharmaceutical systems for over a decade. The strategic rebranding of ZETA Biosystem aims to improve its integration into the international ZETA Group, allowing the company to access a wide range of resources and expertise.
